CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Vasomotor symptoms, such as hot flashes, are widely recognized, but there are dozens of other menopausal symptoms that a woman can experience. Not All Menopausal Symptoms Are the Same, in Terms of ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Radiofrequency (RF) therapy is another non-hormonal approach that is gaining popularity. This innovative treatment employs controlled radiofrequency energy to heat the vaginal tissues, which promotes ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

There are estrogen receptors in your breast tissue, which means a drop in estrogen can lead to breast changes, Dr. Streicher ...